EUVIMEDEUVIMED entdecken
Open Access

In-Cell Approach to Evaluate E3 Ligases for Use in Targeted Protein Degradation

Yunan Zheng, Anamika Singh, Zeqi Niu iD, Violeta Marin, Jonathon Young, Paul Richardson, Marcus L Hemshorn, Richard B Cooley iD, P Andrew Karplus, Kedar Puvar, Scott E Warder, Anil Vasudevan iD und 2 weitere

Journal of the American Chemical Society · 25.06.2025 · 147 (25) · 21560-21574

DOI: 10.1021/jacs.5c02741 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Chemical Society, online erschienen am 10.06.2025. Verfasst von Yunan Zheng und 13 weiteren Autor:innen. Beteiligte Einrichtung: Technology & Therapeutic Platforms, AbbVie Inc., North Chicago, Illinois 60064, United States. Hauptthemen laut MEDLINE: Ubiquitin-Protein Ligases, Proteolysis, Proteolysis Targeting Chimera. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NCRR NIH HHS, National Institute of General Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ubiquitin-Protein LigasesProteolysisProteolysis Targeting ChimeraGenetic CodeAmino AcidsClick ChemistryCyclooctanesBromodomain Containing ProteinsNuclear ProteinsHumansHEK293 CellsRepressor ProteinsTranscription FactorsAdaptor Proteins, Signal Transducing

Substanzen

Ubiquitin-Protein LigasesAmino AcidsCyclooctanesCRBN protein, humanBRD2 protein, humanBromodomain Containing ProteinsSPOP protein, humanNuclear ProteinsProteolysis Targeting ChimeraRepressor Proteins

Autor:innen und Institutionen

  • Technology & Therapeutic Platforms, AbbVie Inc., North Chicago, Illinois 60064, United States.
  • Department of Biochemistry and Biophysics and GCE4All Research Center, Oregon State University, Corvallis, Oregon 97331, United States.

ORCID-Profile: Zeqi Niu, Richard B Cooley, Anil Vasudevan, Justin M Reitsma, Ryan A Mehl

Förderung

  • NIGMS NIH HHS
  • NCRR NIH HHS
  • National Institute of General Medical Sciences

Zitieren

APA

Zheng, Y., Singh, A., Niu, Z., Marin, V., Young, J., Richardson, P., Hemshorn, M. L., Cooley, R. B., Karplus, P. A., Puvar, K., Warder, S. E., Vasudevan, A., Reitsma, J. M., & Mehl, R. A. (2025). In-Cell Approach to Evaluate E3 Ligases for Use in Targeted Protein Degradation. Journal of the American Chemical Society, 147(25), 21560-21574. https://doi.org/10.1021/jacs.5c02741

Vancouver

Zheng Y, Singh A, Niu Z, Marin V, Young J, Richardson P, et al. In-Cell Approach to Evaluate E3 Ligases for Use in Targeted Protein Degradation. Journal of the American Chemical Society. 2025;147(25):21560-21574. doi:10.1021/jacs.5c02741

BibTeX
@article{Zheng2025,
  author = {Zheng, Yunan and Singh, Anamika and Niu, Zeqi and Marin, Violeta and Young, Jonathon and Richardson, Paul and Hemshorn, Marcus L and Cooley, Richard B and Karplus, P Andrew and Puvar, Kedar and Warder, Scott E and Vasudevan, Anil and Reitsma, Justin M and Mehl, Ryan A},
  title = {In-Cell Approach to Evaluate E3 Ligases for Use in Targeted Protein Degradation},
  journal = {Journal of the American Chemical Society},
  year = {2025},
  volume = {147},
  number = {25},
  pages = {21560--21574},
  doi = {10.1021/jacs.5c02741}
}
Kostenlos starten →